Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
Open Access
- 27 September 2008
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (4), 426-435
- https://doi.org/10.1093/eurheartj/ehn562
Abstract
Oral antiplatelet drugs are a cornerstone of modern pharmacotherapy in cardiovascular atherothrombotic diseases. The efficacy of acetylsalicylic acid (ASA, aspirin) and clopidogrel in decreasing the risk of adverse events in coronary heart disease patients has been well established in the past 20 years. Despite chronic oral antiplatelet therapy, a number of atherothombotic events continue to occur. In recent years, a number of reports in the literature have shown possible relationships between residual platelet activity, as measured with a variety of laboratory tests, and clinical outcome, raising the possibility that ‘resistance’ to oral antiplatelet drugs may underlie many such clinical adverse events. The present position paper, conveyed within a group of clinical cardiologists with expertise in thrombosis appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, has been further elaborated and endorsed by the Working Group on Thrombosis of the European Society of Cardiology. It aims at summarizing the main findings in this complex area, issuing opinions in cases of high controversy, and fostering future research in this area to obtain reliable laboratory and clinical data for the resolution of the many problems still open.This publication has 83 references indexed in Scilit:
- One-Year Cardiovascular Event Rates in Outpatients With AtherothrombosisJama-Journal Of The American Medical Association, 2007
- Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy VolunteersStroke, 2006
- Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 2005
- Resistance to antiplatelet drugs: current status and future researchExpert Opinion on Pharmacotherapy, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJournal of the American College of Cardiology, 2005
- The way I see it: House officers need formal career developmentBMJ, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationThe New England Journal of Medicine, 2001
- Platelet-Active DrugsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- Ticlopidine and ClopidogrelCirculation, 1999
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996